CAIM
BHVN icon

Catherine Avery Investment Management’s Biohaven BHVN Stock Holding History

Catherine Avery Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179 Buy
+12
New +$129 ﹤0.01% 164
2026
Q1 		– Sell
-12
Closed -$135 – 113
2025
Q4 		$135 Hold
12
– – ﹤0.01% 156
2025
Q3 		$180 Hold
12
– – ﹤0.01% 159
2025
Q2 		$169 Hold
12
– – ﹤0.01% 163
2025
Q1 		$288 Hold
12
– – ﹤0.01% 158
2024
Q4 		$448 Buy
+12
New +$560 ﹤0.01% 166

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Catherine Avery Investment Management's BHVN Position: Q2 2026 in Review

Catherine Avery Investment Management opened a new position in Biohaven (BHVN) in Q2 2026: 12 shares worth $179. The stake represents ﹤0.01% of the portfolio and ranks #164 among its holdings. This is a return to the name: Catherine Avery Investment Management previously reported a position in BHVN as recently as Q4 2025.

Catherine Avery Investment Management first reported a position in BHVN in Q4 2024 and has held it in 6 quarters since. The position peaked at $448 in Q4 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Catherine Avery Investment Management held 12 shares of Biohaven worth $179 as of Q2 2026.
  • Biohaven was a new Catherine Avery Investment Management position in Q2 2026.
  • Biohaven made up ﹤0.01% of Catherine Avery Investment Management's portfolio in Q2 2026, its #164 holding.
  • Catherine Avery Investment Management first reported a position in Biohaven in Q4 2024 and has held it in 6 quarters since.
  • Catherine Avery Investment Management's Biohaven position peaked at $448 in Q4 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Catherine Avery Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.